European Journal of Cancer
(EUR J CANCER) 《欧洲癌症杂志》
2015年影响因子
6.163
期刊介绍
《欧洲癌症杂志》是国际综合性肿瘤期刊,出版有关基础和临床前研究,临床肿瘤学(医疗,儿科,放射,手术),癌症流行病学和预防的原始研究,社论评论,评论文章和新闻。
展开
推荐阅读
- 2016-09-07•《Eur. J. Cancer》EORTC 24954 III期喉癌治疗试验:喉保留或喉切除?
- 2016-05-12•抗PD-1疗法的神经系统、呼吸系统、肌肉骨骼、心脏和眼科不良事件
- 2016-05-11•PD-1受体抑制剂可引起皮肤不良反应
- 2016-03-11•胰腺癌治疗进展
- 2015-06-24•宫颈狭窄发生率与宫颈切除术的手术方法有关
- 2015-02-22•标准剂量BEP方案可用于治疗卵巢卵黄囊瘤
- 2014-01-04•舒尼替尼对于肾功能不全的转移性肾细胞癌患者的安全性和毒性
- 2013-09-25•转移性肾细胞癌患者接受舒尼替尼的客观缓解:对1059例参与临床试验患者的分析
- 2013-09-09•阿比特龙治疗去势抵抗性转移性前列腺癌接受多西他赛治疗失败患者的疗效
- 2013-08-09•胃肠道间质瘤的诊断、预后和治疗以及KIT外显子13的生殖细胞系突变
- 2013-08-09•每周紫杉醇+S-1与紫杉醇+5-氟尿嘧啶治疗晚期胃癌的对比研究:多中心随机试验结果
- 2012-10-31•早期高危HER-2阳性乳腺癌伴CXCL13-CXCR5 mRNA过表达的患者预后较好
- 2013-10-31•含NK-1 受体拮抗剂阿瑞匹坦的三联止吐方案在高度和中度致呕性多日化疗中的疗效和安全性
- 2013-10-28•口服NK1 受体拮抗剂阿瑞匹坦联合标准止吐药可预防顺铂为基础的化疗多个周期中的恶心呕吐:2 项随机、安慰剂对照、III 期临床试验的汇总分析
- 2013-10-15•肥胖会增加雌激素受体阴性HER2阳性乳腺癌患者远处转移率
- 2013-09-16•保乳术后放疗或他莫昔芬治疗的乳腺癌患者预后良好:英国肿瘤外科协会(BASO)II期临床试验
- 2013-09-12• 40岁及以下接受保乳治疗的乳腺癌患者局部复发情况随访:一项基于1143人的风险趋势和预后影响因素研究
- 2013-08-26•老年危险因素对聚乙二醇化脂质体型阿霉素在老年转移性乳腺癌患者中耐受性和疗效的影响:DOGMES多中心GINECO试验的最终结果
- 2014-07-01•新发糖尿病与胰腺癌风险的关系:一个病例对照研究
- 2014-07-01•糖尿病与胰腺癌的患病风险:一个队列研究的荟萃分析
目录导读
Published 2012年9月,Volume 48,Issue 13
最新一期
Special series - rare tumours | ||||
---|---|---|---|---|
Article Title | Author(s) | Pages | ||
Carcinoma of endocrine organs: Results of the RARECARE project
|
Jan Maarten van der Zwan, Sandra Mallone, Boukje van Dijk, Magdalena Bielska-Lasota,et al. | 1923-1931 | ||
Breast cancer | ||||
Article Title | Author(s) | Pages | ||
Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer
|
Rupert Bartsch, Zsuzsanna Bago-Horvath, Anna Berghoff, Catharina DeVries, et al. | 1932-1938 | ||
Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?
|
Laetitia Huiart, Anne-Déborah Bouhnik, Dominique Rey, Carole Tarpin, et al. | 1939-1946 | ||
Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi-institutional European database
|
Carlos A. Garcia-Etienne, Mariano Tomatis, Joerg Heil, Kay Friedrichs, et al. | 1947-1956 | ||
Lung cancer | ||||
Article Title | Author(s) | Pages | ||
Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium
|
Michele L. Coté, Mei Liu, Stefano Bonassi, Monica Neri, et al. | 1957-1968 | ||
Gastrointestinal oncology | ||||
Article Title | Author(s) | Pages | ||
Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada
|
Lindsay Hedden, Hagen Kennecke, Diego Villa, Karrisa Johnston, et al. | 1969-1976 | ||
Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma
|
Liping Chen, Qi Zhang, Wenjun Chang, Yan Du,et al. | 1977-1987 | ||
Gynecologic oncology | ||||
Article Title | Author(s) | Pages | ||
SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2promoter and reduces the risk of endometrial but not prostatic cancer
|
Stian Knappskog, Jone Trovik, Janusz Marcickiewicz, Solveig Tingulstad, et al. | 1988-1996 | ||
Successful centralisation of patients with vulvar carcinoma: A population-based study in The Netherlands
|
Loes C.G. van den Einden, Katja K.H. Aben, Leon F.A.G. Massuger, Dick Johan van Spronsen, et al. | 1997-2003 | ||
Melanoma | ||||
Article Title | Author(s) | Pages | ||
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
|
Reinhart Speeckaert, Karim Vermaelen, Nanja van Geel, Philippe Autier, et al. | 2004-2011 | ||
Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
|
Y. Brandberg, S. Aamdal, L. Bastholt, M. Hernberg, et al. | 2012-2019 | ||
Pediatric oncology | ||||
Article Title | Author(s) | Pages | ||
Local therapy is critical in localised pelvic rhabdomyosarcoma: Experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee
|
Yves Réguerre, Hélène Martelli, Annie Rey, Timothy Rogers,et al. | 2020-2027 | ||
A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma
|
Nicolas U. Gerber, Katja von Hoff, André O. von Bueren, Wiebke Treulieb,et al. | 2028-2036 | ||
Quality of life | ||||
Article Title | Author(s) | Pages | ||
Socio-economic implications of cancer survivorship: Results from the PROFILES registry
|
Floortje Mols, Melissa S.Y. Thong, Pauline Vissers, Tamar Nijsten, et al. | 2037-2042 | ||
Policy | ||||
Article Title | Author(s) | Pages | ||
Cancer risk and prevention in a globalised world: Solving the public policy mismatch
|
R. Sullivan, L. Homberg, A.D. Purushotham | 2043-2045 | ||
Epidemiology | ||||
Article Title | Author(s) | Pages | ||
Trends of cutaneous squamous cell carcinoma in the Netherlands: Increased incidence rates, but stable relative survival and mortality 1989–2008
|
L.M. Hollestein, E. de Vries, T. Nijsten | 2046-2053 | ||
Basic and preclinical research | ||||
Article Title | Author(s) | Pages | ||
Comparative evaluation of the biological properties of reducible and acid-sensitive folate prodrugs of a highly potent doxorubicin derivative
|
Khalid Abu Ajaj, Naser El-Abadla, Pia Welker, Samar Azab, et al. | 2054-2065 | ||
Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes
|
Cornelia Liedtke, Jens Packeisen, Kenneth R. Hess, Ulf Vogt, et al. | 2066-2074 | ||
Edible oil adulterants, argemone oil and butter yellow, as aetiological factors for gall bladder cancer
|
Vivek Mishra, Manjari Mishra, Kausar M. Ansari, Bhushan P. Chaudhari, et al. | 2075-2085 | ||
Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrest
|
Jingwei Shao, Jinping Xue, Yongchao Dai, Hong Liu, et al. | 2086-2096 |
发表评论网友评论(0)